🇯🇵 Dupixent in Japan

PMDA authorised Dupixent on 19 January 2018

Marketing authorisation

PMDA — authorised 19 January 2018

  • Marketing authorisation holder: Sanofi KK
  • Status: approved

Dupixent in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Japan

Frequently asked questions

Is Dupixent approved in Japan?

Yes. PMDA authorised it on 19 January 2018.

Who is the marketing authorisation holder for Dupixent in Japan?

Sanofi KK holds the Japanese marketing authorisation.